Deaths from prostate cancer have fallen by a fifth in 20 years, new figures from Cancer Research UK show.
The charity believes this is due to earlier, more widespread use of hormone therapy, radical surgery and radiotherapy, as well as earlier diagnosis through the PSA test.
In the early 1990s there were around 30 deaths per 100,000 men, but this has fallen to 24 deaths per 100,000.
But Cancer Research UK has warned that more needs to be done to further reduce the number of men dying from the disease.
Professor Malcolm Mason, Cancer Research UK’s prostate cancer expert said it’s still unclear why some prostate cancers turn out to be harmless, while others are aggressive and resistant to treatment.
He said: “This new report shows we’ve come along way in improving the treatment of prostate cancer in the last couple of decades.
“And improvements in how we treat prostate cancer have been key to reducing deaths from the disease. But a lot more work still needs to be done.”
You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?